Involvement of patients and consumers in the Agency's activities
Patients and consumers are the end-users of the medicines that the European Medicines Agency evaluates, so they are key stakeholders with specific knowledge and expertise to offer the Agency.
The Agency is committed to maintaining a strong working relationship with patients and consumers and is interacting with a growing number of patients’ and consumers’ organisations.
See more information on the Agency's work with patients and consumers.
Searching for medicines by therapeutic area
It is possible to browse for a medicine by therapeutic area. The Agency categorises each medicine it assesses using a taxonomy which can be easily browsed. Go to European public assessment reports (EPARs) and use the 'browse by therapeutic area' tab.
Beware of falsified medicines!
Falsified medicines are fake medicines that may enter the supply chain illegally. Be careful about the way you buy medicines. Find more information on falsified medicines.
Search for herbal medicines
The Agency is responsible for supporting the harmonisation of herbal medicinal products in Europe. Search for herbal medicines assessed by the Agency's Committee on Herbal Medicinal Products.
News for patients and carers
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 September 2014
Fifteen new medicines and three extensions of indication recommended for approval ... Read more
European Medicines Agency facilitates patients' access to a treatment of a rare hormonal disorder ... Read more
The European Medicines Agency (EMA) has started to review available information on Ebola treatments currently under development. ... Read more
Measures introduced to improve monitoring of liver function during treatment ... Read more
Patients to discuss benefit-risk evaluation of medicines with the Committee for Medicinal Products for Human Use
EMA launches pilot project to integrate patients’ unique and critical views into CHMP discussions ... Read more
- See all News for patients and carers
Events of interest
Eighth stakeholders forum on the implementation of the pharmacovigilance legislation: Building on two years of operation
The meeting will allow attendees to discuss the current status of implementation, building on two years of operation of the European Union pharmacovigilance system as well as various on-going EU-wide initiatives. Registration by invitation only. ... Read more
30/09/2014 - 01/10/2014
Joint European Forum for Good Clinical Practice / Drug Information Association / European Medicines Agency: Better medicines for children conference
The aim of this conference is to discuss on a high level how the European Union paediatric regulation is working and how it contributes to children’s health. This will include a discussion on the preparedness for the 10-year report, strategic thoughts within the European Medicines Agency on how to streamline paediatric development and a session dedicated to paediatric oncology. Experts from all involved parties will be present, and on day one, participants will discuss more specialised issues in four breakout sessions. Places limited. ... Read more
European Medicines Agency Human Scientific Committees' Working Party with Patients’ and Consumers’ Organisations (PCWP) and Healthcare Professionals Working Party (HCPWP) joint meeting
This is a joint meeting with representatives from patients', consumers' and healthcare professionals' organisations. Participants will be updated on a number of EMA initiatives including RMP summaries, conflicts of interest policy and access to clinical trial data policy. The European Commission will provide updates on the new clinical trial regulation and a study on off-label use. Feedback from four NCAs involving patients and healthcare professionals in regulatory decisions will be discussed in the afternoon session. Registration by invitation only. ... Read more
European Medicines Agency Human Scientific Committees' Working Parties with Patients’ and Consumers’ Organisations (PCWP) and Healthcare Professionals’ Organisations (HCPWP) joint meeting - Workshop on benefit-risk communication
This is a joint Workshop with representatives from patients', consumers' and healthcare professionals' organisations. The workshop will provide an overview of how EMA communicates on the benefits and risks of medicines within the EU regulatory network. It will also discuss the role of communication in achieving effectiveness of risk minimisation measures and explore how such communication can support healthcare professionals and patients on their treatment decisions. Registration by invitation only. ... Read more
European Medicines Agency Human Scientific Committees' Working Parties with Patients’ and Consumers’ Organisations (PCWP) and Healthcare Professionals’ Organisations (HCPWP) joint meeting
This is a joint meeting with representatives from patients’, consumers’ and healthcare professionals’ organisations. Participants will be updated on a number of European Medicines Agency (EMA) initiatives including EMA adaptive licensing pilot project, health-technology assessment-EMA interaction, assessing the impact of pharmacovigilance and EMA communication on medication errors. The PCWP/HCPWP work programmes 2015 will also be discussed. Registration by invitation only. ... Read more
- See all Events of interest